Life ScienceCompany
Zevra Therapeutics M&A Summary
Zevra Therapeutics has acquired 1 company, including 1 in the last 5 years.
Zevra Therapeutics’ largest acquisition to date was in 2023, when it acquired Acer Therapeutics for $91M. Zevra Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Zevra Therapeutics Business Overview
Where is Zevra Therapeutics headquartered?
Zevra Therapeutics is headquartered in Celebration, Florida.
What is Zevra Therapeutics’ revenue?
Zevra Therapeutics disclosed revenue of 10M USD for 2022 and 29M USD for 2021.
How many employees does Zevra Therapeutics have?
Zevra Therapeutics has 65 employees.
What sector is Zevra Therapeutics in?
Zevra Therapeutics is a life science company.
When was Zevra Therapeutics founded?
Zevra Therapeutics was founded in 2006.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 2